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Introduction: Cardiac index is a hemodynamic parameter defined as the ratio of the cardiac 
output, i.e., the volume of blood ejected from the left ventricle in 1 min, to the body surface 
area. This study aimed to assess the cardiac index to predict early and 30-day outcomes of 
non-cardiac patients being admitted to intensive care units using a non-invasive approach. 
Materials and Methods: This prospective cohort study included 31 non-cardiac patients 
who were consecutively admitted to the intensive care units of Rasoul-e-Akram Hospital, 
Tehran, Iran, in 2016. On admission, the simplified acute physiology score II to predict 
mortality and the cardiac output (by two-dimensional echocardiography) of each patient 
were determined. The cardiac index was calculated by dividing the cardiac output by the 
body surface area. In-hospital mortality and complications were assessed, and the association 
between simplified acute physiology score II and cardiac index was determined. The patients 
were followed-up 30 days after discharge by telephone to determine late death, occurrence of 
myocardial infarction, readmission, or re-hospitalization. Results: The mean cardiac index 
was significantly lower among the patients who died in intensive care units  than in those 
who survived (2.86 ± 0.63 versus 3.70 ± 0.49, p = 0.006). A significant inverse association 
was found between Simplified Acute Physiology Score II and cardiac index (r = −0.539, 
p = 0.002). The length of hospital and intensive care units stay was not associated with 
Simplified Acute Physiology Score -II or cardiac index. The receiver operating characteristic 
curve analysis revealed that the cardiac index was effective in predicting in intensive care 
units mortality (area under curve = 0.857, p = 0.007). The best cut-off value for the cardiac 
index to predict in intensive care units mortality was 3.35, yielding a sensitivity of 83.3% 
and a specificity of 80.0%. Conclusion: Measuring the cardiac index during intensive care 
units admission using a noninvasive approach even in non-cardiac patients can predict in 
intensive care units mortality with high sensitivity and specificity.
INTRODUCTION
Cardiac index (CI) is a hemodynamic parameter defined 
as the ratio of the cardiac output, i.e., the volume of blood 
ejected from the left ventricle in 1 min, to the body surface 
area (BSA). It is a useful indicator of how well the heart 
is functioning as a pump (4) and is directly related to 
some cardiac characteristics, such as the power of heart 
performance, myocardial contractility, and cardiac size; 
thus, it tends to vary between individuals (1,2). The CI 
is usually assessed in critically ill patients to determine 
their cardiac function. Thermo-dilution via pulmonary 
artery catheter is a gold standard technique to measure 
the cardiac output (3). The CI is also considered as an 
important physiological and metabolic indicator of the 
metabolic status of various organs because the cardiac 
output is closely associated with the metabolic health 
of the organs (5,6). The cardiac function as a pump 
deteriorates due to several factors such as excessive weight 
and intraventricular conduction disorders in patients with 
acute coronary syndrome (7, 8).
Thus, it can be expected that the CI is considerably reduced 
in patients with functional impairment of vital organs, such 
as heart failure patients, critically ill patients, or those with 
metabolic disturbances. In addition, because many patients 
do not complete follow-up so  refuse to undergo invasive 
procedures, CI assessment via noninvasive approaches 
will be valuable for determining the degree of cardiac 
performance or metabolic dysfunction (9).
Hence, the present study aimed to assess the CI to predict 
early and 30-day outcomes of non-cardiac patients being 
admitted to intensive care units (ICUs) using a noninvasive 
approach. 
MATERIALS AND METHODS
This prospective cohort study included 31 non-cardiac 
patients who were consecutively admitted to the ICUs of 
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Rasoul-e-Akram Hospital, Tehran, Iran, in 2016. The study 
was approved by the ethics committee of Iran University 
of Medical Sciences and was conducted in accordance 
with the 1975 Declaration of Helsinki. Written informed 
consent was obtained from each patient prior to enrollment 
in this study. On admission to ICUs, the simplified acute 
physiology score (SAPS) II index of all patients was 
determined to predict their hospital mortality. Further, 
the cardiac output, left ventricular ejection fraction, and 
other cardiac functional parameters of all patients also 
determined by two-dimensional echocardiography by 
a single cardiologist. The CI was calculated by dividing 
the cardiac output by the BSA, which was calculated 
using the following formula provided by Kelley et al. 
(10) for measuring the BSA of female swine: BSA (m2) 
= 0.0734 × Weight (kg)0.656. In-hospital mortality and 
complications, including increased troponin levels, serum 
creatinine levels, prolonged intubation, and other cardiac 
complications, were also assessed. To determine the 
long-term outcomes, the patients were followed-up 30 
days after discharge by telephone to determine late death, 
occurrence of myocardial infarction, readmission, or re-
hospitalization.
The results are presented as the mean ± standard deviation 
(SD) for quantitative variables and as absolute frequencies 
and percentages for categorical variables. Normality of the 
data was analyzed using the Kolmogorov–Smirnoff test. 
Quantitative variables were compared using the t-test or 
Mann–Whitney U test. The correlation between the study 
parameters was assessed using the Pearson’s correlation 
test. The predicting power of the CI for discriminating 
between survived and non-survived patients was assessed 
using the area under the receiver operating characteristic 
(ROC) curve/area under curve (AUC) analysis. The ROC 
curve represents the ability of a parameter to discriminate 
between the true and false statuses in the same patient 
(11). The SPSS version 16.0 statistical software for 
Windows (SPSS Inc., Chicago, IL) was used for the 
statistical analyses. P values of ≤0.05 were considered 
statistically significant.
RESULTS
The baseline characteristics of the study patients are 
summarized in Table 1. Thirty-one patients with the 
mean age of 64.97 ± 16.88 (range, 19–84) years and the 
mean body mass index (BMI) of 27.16 ± 2.24 kg/m2 were 
included, 58.1% of whom were male. The most frequent 
cardiovascular risk factors were smoking (35.5%), followed 
by hypertension (22.6%). Overall, one-third of the patients 
had left ventricular ejection fraction of 0.50. Twenty-one 
patients were directly admitted to the ICUs, whereas the 
others were transferred from the general ward to the ICUs. 
The main indications for ICU admission were gastric cancer 
(one case), pulmonary adenocarcinoma (one case), huge 
ascites (one case), chronic obstructive pulmonary disease 
exacerbation (one case), diabetic ketoacidosis (one case), 
post-esophagostomy (one case), gastrointestinal bleeding 
with pneumonia (one case), glioma symptoms (one 
case), hospital-acquired pneumonia(one case), metastatic 
ovarian cancer (one case), peritonitis (one case), aspiration 
pneumonia (seven cases), pneumosepsis (six cases), 
primary sepsis (four cases), shunt-related infection (one 
case), thyroid cancer (one case), and trauma (one case). 
The mean length of ICU stay was 26.60 ± 36.68 (range, 
2–133) days. The most common in-ICU complications 
were related to thromboembolic events (13.0%), renal 
failure (45.2%), cardiac arrhythmias (29.0%), cardiac 
arrest (58.1%), and various infections (80.6%). The mean 
length of complete hospital stay was 34.61 ± 36.48 (range, 
2–133) days. The in-ICU mortality rate was 80.6%.The 30-
day post-discharge follow-up revealed that one patient had 
died within 25 days after hospital discharge; this increased 
the 30-day mortality rate to 86.7%. This follow-up also 
revealed that two patients were re-hospitalized. 
The mean SAPS II was 52.39 ± 14.45 (range, 21–89), 
and the mean CI was 3.03 ± 0.69 (range, 0.80–4.20). The 
mean SAPS II was significantly higher in the in-ICU non-
survived group than in the survived group (54.36 ± 13.85 
versus 44.17 ± 15.20, p = 0.002). In addition, the mean 
CI was significantly lower in the in-ICU non-survived 
group than in the survived group (2.86 ± 0.63 versus 3.70 
± 0.49, p = 0.006). These results indicated a significant 
inverse correlation between SAPS-II and CI (r = −0.539, 
r2 = 0.291, p = 0.002) (Figure 1). Further, among patients 
with SAPSII <40, all had CI ≥ 3, whereas among those 
with SAPS II > 40, only 44.0% had CI > 3.These findings 
confirmed the significant inverse association between 
SAPSII and CI. The length of ICU stay was not associated 
with SAPS II (r2 = 0.001, p = 0.945) or CI (r = 0.075, r2 = 
0.006, p = 0.687). Similarly, the mean length of complete 
Table 1. Baseline characteristics of study population
Variable Descriptive statistics
Age (Mean) 64.97 ± 16.88
BMI (Mean) 27.16 ± 2.24
Pao2, mmHg (Mean) 65.26 ± 28.58
Fio2, mmHg (Mean) 49.39 ± 9.54
24h-urinary volume, mL (Mean) 2200.00 ± 1037.22
GCS Score (Mean) 8.06 ± 3.77
Male Gender (%) 58.1
History Of Cerebrovascular 
Disorders (%)
19.4
History Of Diabetes (%) 19.4
History Of Dyslipidemia (%) 3.2
History Of Hypertension (%) 22.6
History Of Cigarette Smoking (%) 35.5
History Of Opium Use (%) 12.9
Left Ventricular Ejection Fraction of 
0.50 (%)
32.3%
Left Ventricular Ejection Fraction of 
0.55 (%)
41.9%
Left Ventricular Ejection Fraction of 
0.60 (%)
25.8%
Needing mechanical ventilation (%) 93.5%
(Abbreviations; BMI:  Body Mass Index, Pao2: , Fio2: , GCS: )
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hospital stay was not associated with SAPS II (r = −0.088, 
r2 = 0.008, p = 0.637) or CI (r = 0.091, r2 = 0.008, p = 
0.625). The ROC curve analysis (Figure 2) revealed that 
the CI could effectively predict the in-ICU mortality (AUC 
= 0.857, p = 0.007). The best cut-off value for the CI to 
predict in-ICU mortality was 3.35, yielding a sensitivity of 
83.3% and a specificity of 80.0%. 
DISCUSSION
The CI is a valuable parameter for estimating the cardiac 
performance in relation to the BSA. Although usually used 
to determine the cardiac output of critically ill patients, our 
results showed that it can also be valuable in predicting 
the outcome of patients being admitted to ICUs. In this 
study, we introduced CI as a valuable index for predicting 
mortality similar to SAPS II, a powerful indicator of in-
ICU mortality among critically ill patients. In our patient 
cohort, a lower CI reflected a higher risk of in-ICU death, 
indicating that the CI could effectively discriminate between 
survived and non-survived conditions with high sensitivity 
and specificity. However, one death occurred during the 
first 30 days after discharge; therefore, we could not assess 
the value of CI to predict 30-day mortality. In addition, no 
significant association was found between the CI and the 
length of ICU or complete hospital stay, indicating that the 
CI cannot predict the duration of hospitalization.
Many studies have reported the power of CI to predict 
mortality in ICU patients. For example, in the study 
by Fincke et al. (12), CI was the only parameter used 
to predict in-hospital mortality of patients undergoing 
cardiogenic shock. However, only cardiac patients were 
assessed in their study. In another study by Soussi et al. 
(13), 30-day mortality was considerably lower (42.0%) 
than that in our study, indicating that the condition of our 
patients was worse. However, consistent with our results, 
the CI assessed during admission in their study could 
also effectively predict early mortality. In another study, 
Kimmoun et al. (14) assessed the CI during admission as 
well as 24 hours after admission. In their study, SAPS II 
of>58 and CI were predictive of 30-day and in-hospital 
mortalities, consistent with our findings. 
Several invasive techniques are available for CI assessment, 
including transpulmonary thermos-dilution technique, 
angiography, and impedance cardiography. However, their 
use has now decreased because of their invasive nature 
and their poor ability to determine the cardiac functional 
status. For instance, as indicated by Eiferman et al. (15) 
following the introduction of pulmonary artery catheter 
(PAC) and recognition of the importance of preload as 
a critical determinant of the cardiac function, various 
hemodynamic monitoring methods were developed 
to assess cardiac function parameters, such as cardiac 
output or cardiac index; however, the lack of concordance 
between these devices has been also revealed in critically 
ill patients. Because our study mainly aimed to determine 
the prognostic value of CI and our patients were reluctant to 
undergo invasive methods for measuring CI, we estimated 
the CI using a noninvasive approach, i.e., by dividing the 
cardiac output by the BSA as previously described (16,17).
The present study had some limitations. First, the small 
sample size of the study could have resulted in inadequate 
power to determine between-parameter associations 
while considering potential confounding factors. Second, 
because the CI was not determined using invasive methods, 
measurement biases while measuring the cardiac output 
and BSA cannot be ruled out.
CONCLUSION
In conclusion, measuring the CI during ICU admission 
using a noninvasive approach even in non-cardiac patients 
can predict in-ICU mortality with high sensitivity and 
specificity. However, the CI cannot predict the length of 
hospital or ICU stay.
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Figure 1. Reverse association between SAPS II and CI 
(Abbreviations; SAPS II: simplified acute physiology score II, CI: cardiac 
index) 
 
Figure 2. The ROC curve analysis to assess the value of CI to 
predict in-ICU mortality
(Abbreviations; ROC: receiver operating characteristic, CI: cardiac index, 
ICU: intensive care unit)
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